Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

131results about How to "Maintain osmotic pressure" patented technology

Phosphorus-free water-retaining agent for meat products and aquatic products and preparation method thereof

The invention relates to a water-retaining agent and a preparation method thereof, in particular to a water-retaining agent for meat products and aquatic products and a preparation method thereof, belonging to the technical field of food additives. The water-retaining agent is formulated from the following raw materials in parts by weight: 20-50 parts of whey protein, 20-30 parts of potassium carbonate, 10-20 parts of potassium citrate, 10-15 parts of sodium bicarbonate and 10-15 parts of glucono-delta-lactone. The phosphorus-free water-retaining agent can be used for meat products and aquatic products. With the adoption of the phosphorus-free water-retaining agent, the weight and water binding capacity of the products during soaking, cold storage, thawing and the like can be significantly improved, the yield of the products is improved, and water loss of the products during processing, cold storage, thawing can be prevented. The phosphorus-free water-retaining agent is free of phosphorus, so that the problems that the content of phosphate exceeds a standard, unpleasant metal smell is produced after the products are cooked, the texture of the products is coarse and the like due to addition of phosphate water-retaining agents can be avoided.
Owner:LIUZHOU CHANGYUAN FOOD INGREDIENTS SCI & TECH CO LTD

Combined medicament for supplementing zinc and calcium and preparation method thereof

The invention relates to a combined medicament for supplementing zinc and calcium and a preparation method thereof. Medicament components are released at a fixed part. The preparation method comprises the following steps of: taking zinc gluconate and vitamin D, adding medicinal starch and microcrystalline cellulose and mixing, adding crushed superfine silica gel powder and evenly mixing and sub-packaging into enteric capsules; and mixing water-soluble calcium acetate, the medicinal starch and the microcrystalline cellulose, adding the crushed superfine silica gel powder and evenly mixing and sub-packaging into Muslim capsules. The medicament and the preparation method thereof ensure that the vitamin D cannot be damaged in an acid environment, avoid the direct stimulation of the zinc gluconate to the stomach and block off the direct contact of vitamin E and oxygen. After patients take two kinds of capsules, effective components of the vitamin E and the calcium acetate are rapidly disintegrated and absorbed in the stomach; the vitamin D and the zinc gluconate are disintegrated and absorbed in the intestine; and the invention has the characteristics of taking effect of medicament, high bioavailability, small side effect and the like, and is specially suitable for children, pregnant women, adults and old people for supplement and administration for a long term.
Owner:广西强寿药业集团有限公司

Large-scale production method for clostridium butyricum

The invention relates to a large-scale production method for clostridium butyricum. The method comprises the following steps: (1) preparing a clostridium butyricum suspension with clostridium butyricum colonies of slant culture; (2) inoculating the clostridium butyricum suspension into fermentation broth in a seed tank, and performing anaerobic culture to a logarithmic growth phase to obtain fermentation strains; and (3) inoculating fermentation strains into the fermentation broth in a fermentation tank, and performing large-scale anaerobic fermentation production to obtain a clostridium butyricum product with a living bacteria number greater than 10<8>CFU/ml. The method prepares the clostridium butyricum suspension with a clostridium butyricum lawn on a slant culture medium, and then inoculates the clostridium butyricum suspension into the seed tank for anaerobic fermentation, and experimental results show that the same fermentation effect as a clostridium butyricum fermentation seedsolution can be achieved; the method does not require secondary expanding culture, so that the fermentation cycle is shortened by at least one primary seed fermentation cycle in the entire process flow; and meanwhile, at least one strain passage is also reduced, thus reducing the risk of strain variation caused by excessive strain passage.
Owner:HENAN JINBAIHE BIOTECH CO LTD

Later-stage compound feed capable of improving somatotype and meat quality of fattening pigs and processing method of later-stage compound feed

ActiveCN107969560AImprove body shapeThe overall shape is beautifulAccessory food factorsChemistryMagnesium
The invention discloses a later-stage compound feed capable of improving somatotype and meat quality of fattening pigs and a processing method of the later-stage compound feed, and belongs to the technical field of feeds. The later-stage feed is prepared from the following raw materials in percentage by mass: 0.2-0.4% of betaine, 0.02-0.05% of chromium picolinate, 0.01-0.02% of selenium yeast, 0.01-0.02% of vitamin E, 0.01-0.03% of vitamin C, 0.06-0.10% of magnesium sulphate, 0.1-0.2% of potassium chloride, 64.0-66.0% of corn, 20.0-22.0% of soybean meal, 5.0-6.0% of oil bran, 0.8-1.0% of palmoil, 4.0-6.0% of coarse bran, 0.38-0.50% of calcium hydrogen phosphate, 1.05-1.20% of stone powder, 0.40-0.45% of sodium chloride, 0.05-0.07% of an antioxidant and 1.0% of a premix.
Owner:WUHAN JIAJIALE FEED

Novel preservation solution for alveolar lavage fluid microbial nucleic acid

The invention discloses a novel preservation solution for an alveolar lavage fluid microbial nucleic acid. The preservation solution comprises a treatment solution I and a treatment solution II, wherein the treatment solution I comprises a guanidine hydrochloride buffer solution, a nuclease inhibitor, a metabolism inhibitor, an alkali metal halide and glycerol, and the treatment solution II comprises an alkali metal hydroxide and a surfactant. The treatment solution I and the treatment solution II which are separately stored are used as the novel preservation solution for the alveolar lavage fluid microbial nucleic acid, so that the preservation solution can be prevented from generating precipitates, at the same time, different interference impurities can be treated respectively in a targeted manner, alveolar lavage fluid samples can be rapidly stabilized, the activity of nuclease is effectively inhibited, the cell lysis is prevented, at the same time, the free nucleic acid in the alveolar lavage fluid can be well protected, the preservation time is long, the accuracy and convenience of nucleic acid detection are improved, and thereby the preservation solution has great applicationvalue in the detection and diagnosis of tumor diseases, viruses and the like.
Owner:广州源古纪科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products